A Clinician View and Experience of Proteomic Studies in the Light of Lung Cancer in Japanese Healthcare

Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

Abstract

In Japan, rising costs have impacted the framework of maintaining an efficient and effective healthcare system. Today, urgent implementation of programs to address this need have led to a rebuilding of the entire approach of medical evaluation and clinical care. Recent developments in clinical proteomics based on mass spectrometry (MS) for identifying, sequencing, and quantifying disease-relevant protein biomarkers is a promising means for optimal drug prescription using biomarker diagnosis. We illustrate in this report our experience with lung cancer cases with various drug therapies evaluated with proteomics studies.

Detaljer

Författare
  • Harubumi Kato
  • Toshihide Nishimura
  • Takashi Hirano
  • Masaharu Nomura
  • Hiromasa Tojo
  • Kiyonaga Fujii
  • Takeshi Kawamura
  • Sayaka Mikami
  • Makoto Kihara
  • Yasuhiko Bando
  • Masahiro Tsuboi
  • Norihiko Ikeda
  • György Marko-Varga
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Analytisk kemi

Nyckelord

Originalspråkengelska
Sidor (från-till)51-57
TidskriftJournal of Proteome Research
Volym10
Utgivningsnummer1
StatusPublished - 2011
PublikationskategoriForskning
Peer review utfördNej